← Evidence map

ReviewVascular health and risk management2013

Comprehensive overview: efficacy, tolerability, and cost-effectiveness of irbesartan.

Fotini Gialama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 24124375